Home›Stock Screener›Trident Texofab›Financial Statements

Trident Texofab Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Trident Texofab (TTFL) reported revenue ₹118 Cr, net profit ₹1 Cr and EPS ₹0.54, with a net profit margin of 0.8% and ROE of 1.8%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see TTFL stock price BSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 0.85% 2026 data
EBITDA Margin 3.39% 2026 data
Operating Margin 3.00% 2026 data
Return on Assets 0.90% 2026 data
Return on Equity 1.79% 2026 data

Balance Sheet Ratios

Current Ratio 4.33 2026 data
Equity Ratio 50.45% 2026 data
Asset Turnover 1.06 2026 data

TTFL Revenue, Net Profit & EBITDA — Year-on-Year Growth

TTFL YoY (March 2025 vs March 2026) — revenue -5.6%, net profit -66.7%, EBITDA -55.6%, expenses -2.6%. Analyse TTFL FII DII holdings to track promoter, FII and institutional holdings.

Revenue Growth
-5.6%
Year-over-Year
Net Profit Growth
-66.7%
Year-over-Year
EBITDA Growth
-55.6%
Year-over-Year
Expense Growth
-2.6%
Year-over-Year
Assets Growth
+9.9%
Year-over-Year
Equity Growth
+19.1%
Year-over-Year
Operating Cash Flow Growth
-566.7%
Year-over-Year
Investing Cash Flow Growth
-1900.0%
Year-over-Year
Financing Cash Flow Growth
+1950.0%
Year-over-Year

TTFL Income Statement — Revenue, EBITDA & Net Profit

Trident Texofab revenue ₹118 Cr, EBITDA ₹4 Cr, net profit ₹1 Cr, EPS ₹0.54 (2026) — net profit margin 0.8%. Also explore Trident Texofab share price performance to track price trends across different timeframes.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 118 125 100 98 85 52 91 87 86 76 66 63
Expenses 114 117 93 90 80 47 86 85 84 75 65 61
EBITDA 4 9 7 8 6 5 5 3 2 1 1 1
Operating Profit Margin % 3.00% 4.00% 6.00% 7.00% 6.00% 6.00% 5.00% 3.00% 2.00% 2.00% 1.00% 2.00%
Depreciation 2 2 2 2 2 1 1 0 0 0 0 0
Interest 3 5 4 4 3 3 3 1 1 1 1 1
Profit Before Tax 1 3 1 3 1 1 2 2 1 1 0 0
Tax 0 0 0 1 0 1 1 0 0 0 0 0
Net Profit 1 3 1 2 1 0 1 1 1 0 0 0
Earnings Per Share (₹) 0.54 2.44 1.07 2.20 0.98 0.35 0.94 3.19 1.88 9.92 2.18 5.60

TTFL Balance Sheet — Assets, Liabilities & Shareholders' Equity

TTFL total assets ₹111 Cr, total equity ₹56 Cr, total liabilities ₹ Cr (2026) — ROE 1.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 111 101 82 77 71 68 56 47 45 25 38 28
Current Assets 78 74 52 47 40 40 40 36 40 22 36 27
Fixed Assets 18 20 22 23 22 14 13 2 2 1 1 2
Capital Work in Progress 1 0 0 0 4 9 0 6 0 0 0 0
Investments 21 2 4 4 2 3 1 0 0 0 0 0
Other Assets 0 79 56 50 44 42 42 38 43 23 37 27
LIABILITIES
Total Liabilities
Current Liabilities 18 13 23 25 28 26 15 9 4 5 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 56 47 16 15 13 12 12 11 8 4 4 3
Share Capital 15 14 10 10 10 10 4 4 4 0 0 0
Reserves & Surplus 41 30 6 5 3 2 7 7 4 4 3 3

TTFL Cash Flow Statement — Operating, Investing & Financing

Trident Texofab operating cash flow ₹-14 Cr, investing ₹-20 Cr, financing ₹37 Cr, net cash flow ₹3 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -14 3 6 1 2 -3 -3 -3 0 1 0
Investing Activities -20 -1 0 -4 -10 -2 -7 -2 -1 0 1
Financing Activities 37 -2 -6 3 8 5 10 3 2 -1 -1
Net Cash Flow 3 0 0 0 0 0 0 -2 2 0 0